Arterial Hypertension

Αρτηριακή Υπέρταση - hypertension-blood-pressure-measuring

Hypertension or Arterial Hypertension (increased arterial pressure) is one of the most important chronic diseases that people are facing during the past 50 years. It is still the main factor causing coronary artery disease, myocardial infarction, heart failure, stroke, aneurysms of the arteries, and renal failure.

In simple words, arterial pressure depicts how intensively our heart should work, so that the blood can circulate in the body. Each cell of the human organism needs stable blood flow so that oxygen and essential nutrients can be transferred.


Diagnosis of Real Causes & Treatment of Arterial Hypertension

  • Gradual restoration of cellular function
  • Personalized therapeutic protocols, without chemical residues and excipients
  • Treating the real causes
  • Therapeutic formulas that work alone or in combination with any other medication
  • Adopting a Molecular / Therapeutic Nutrition Plan


Hypertension – Categories

Hypertension is classified as essential or primary and secondary. Approximately 90–95% of cases are classified as “Essential Hypertension”, which means high blood pressure, with no obvious medical cause.


How Hypertension develops

Our heart is a pump. It sends clear oxygenated blood through the arteries to the tissues, so that to perform their functions. Then it receives from peripheral veins the used by the tissues, unclean and full of carbon dioxide blood. Each time it sends bloods to the arteries, a pressure is created due to the forces. One force when the blood is sent and another when the arteries resist to the blood’s flow. These are translated to two numbers. Systolic blood pressure (when the heart contracts to send blood), and diastolic pressure (when the heart rests in between pulses).

Υπέρταση και κυκλοφορία - hypertension-circulation

Multiple factors ultimately lead to Hypertension

Constant stress of everyday life

Lack of time


Poor diet

together with the fast pace of life in postmodern societies intensify the pump’s rate, i.e. our heart’s pulses.

As a result, it is over-contracting, and overactive in its attempt to perform its valuable operation. It meets increasingly greater obstacles from inflexible arteries (atheromatosis – atheromatic plaques), “lazy” veins (sedentary lifestyle). It also increases its size (hypertrophic cardiomyopathy) and the pressure it should exert in its attempt to perform its function (Arterial Hypertension). Finally, coronary heart disease, strokes, and renal failure are caused, and a “perpetual cycle” starts.

Hypertension and Statistics

The figures are relentless, since Hypertension leads to a 7-fold increase in the risk of myocardial infarction, 3-fold increase in the risk of coronary heart disease and a 6-fold increase in the risk of cardiac failure.

When it also combined with smoking, obesity and excess weight, hyperlipidemia, stress, and a family history, these risks may be tripled.


Αρτηριακή Υπέρταση - Συμπτώματα

At the same time, internationally, Chronic Diseases of the circulatory system (i.e. diseases associated with Arterial Hypertension – high blood pressure, elevated cholesterol and diabetes), hold by far the first place among the causes of death in the Modern World.

Hypertension is one of the most insidious chronic diseases, as it has no apparent symptoms, only discomfort, caused by its complications. It is also known as the “silent Killer”, as only 1/3 of the patients realize Hypertension from its symptoms.

Until today, doctors monitor blood pressure, perform the necessary heart exams, and prescribe one of the numerous antihypertensive pills; the patient does not receive these drugs at a stable dose, but s/he is constantly monitored, until his/her pressure is regulated to normal levels.

This is the usual approach, based on everyday monitoring standards. The side effects caused, due to the use of pharmaceutical substances, is something that only a few people know, and even fewer report.

Hypertension and its Pathophysiology

Each human being is a unique entity, with its own physiology and biochemistry. This is a fact, which should be taken into account when attempting to regulate arterial pressure of each person separately. To the contrary, till present, prescribing certain drugs seems like a one-way road, since Hypertension is a symptom of an overall pathologic condition.

Stress, obesity, diabetes mellitus, hormonal disorders, hyperlipidemia, metabolic syndrome, are pathological conditions, of which Hypertension is one of their symptoms.

This is because these Chronic pathologic conditions, causing the release of inflammatory cytokines, i.e. they lead to the expression of Chronic Inflammations. These, in turn, encourage the formation and growth of atherosclerotic plaques in the arteries, which in turn become more rigid and inflexible. Thus they force heart to exert more force (pressure) to overcome the obstacle, resulting in Hypertension.

Υπέρταση - Υπερτροφική Μυοκαρδιοπάθεια - hypertension-heart-hypertrophic-cardiomyopathy


Hypertension and Treatment

Thus, one can understand that to solve the problem of the so-called “silent killer”, Hypertension, s/he should solve the problem of Chronic Inflammation.

On the other hand, what is now clear is that we should investigate further our therapeutic approach for Arterial Hypertension.

Micronutrients protocols, according to the American Standards, are differentiated for this Chronic Disease, as well as according to a large number of other factors.

Thus, dosage, duration, quantity and combination of ingredients (formula) are determined on an individual basis for each person.

Biochemical aberration at the functional level in the organism of patients with Hypertension, can be restored. Following the appropriate biochemical and metabolic exams, dysfunctions are detected and existing deficiencies are identified.

There are many exams available to ultimately determine treatment, depending on the patient’s Medical History. The cost of most of them is affordable and the results are ready within two to three days.

Treatment is adjusted depending on the extent of the lesions and the individual findings. It may last from three months to one year to fully restore the patient’s clinical image.

Patients should not change their everyday life. To the contrary, they see their health improving gradually, together with their overall physical condition.

These therapies are systematically used in clinical practice since 1997, and the country of departure was the United States of America. They are not contradictory to any other concurrent pharmaceutical or homeopathic treatment.

The appropriate treatment is that which ultimately provides the best possible benefit, according to the clinical outcomes and the relevant exam markers.




  • Demystifying Weight Loss – Pamela Wartian Smith, M.D. – ISBN: 978-0972976756 Celiac Disease: A Hidden Epidemic – Peter Green, M.D. & Rory Jones – ISBN: 978-0-06-076693-1 – Harper Collins
  • Heindal JJ, Endocrine disruptors and the obesity epidemic, Toxicol Sci 76; 2:247-49, 2003
  • Baillie-Hamilton PF, Chemical toxins: a hypothesis to explain the global obesity epidemic, JAIt Complement Med 8;2:185-92, 2002
  • Alonso-Magdalena P, et al, The estrogenic effect of bisphenol A disrupts pancreatic B-cell function in vivo and induces insulin resistance, Environ Health Perspect 114:106-12, 2006
  • The Hundred Year Diet in the Wall Street (May 10, 2010, A I5)
  • Vom Saal FS, Welshons WV, Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A, Environ Res, 100;1:50-76, Jan. 2006
  • Feige JN, et al, The endocrine disruptor monoethyl-hexyl phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis, JBiol Chem 282:19152-66, 2007
  • Hatch EE, et al., Association of urinary phthalate metabolite concentrations with a body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002, Environ Health 7:27, 2008
  • Clark K, et al, Observed concentrations in the environment. In: The Handbook of Environmental Chemistry. Vol 3, Part Q. Phthalate Ester (Staples CA, ed). New York: Springer, 125-177, 2003
  • Feige JN, et al, The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARa-dependent mechanisms, Environ Health Persp, 118; 2:234-41, Feb 2010
  • Jaakkola JJK, et al, The role of exposure to phthalates from polyvinyl chloride products in the development of asthma and allergies: A systematic review and meta-analysis, Environ Health Perspect 116:845-53, 2008